BioTryp Therapeutics

🔬 BioTryp Therapeutics, a start-up founded by Ashraf Zarkan and David Summers are developing the first anti-biofilm oral therapy for bacterial infections. ℹ️ Before founding the company, the team took part in the first NBIC Biofilms Innovate UK ICURe Sprint, which was funded by NBIC and delivered by the SETsquared Partnership. “With NBIC’s support we managed to transform our university project into a new company” 💬 Dr Zarkan Read the full case study ➡️ tinyurl.com/bde5p5mz #BiofilmWeek #WAAW #AMR #biofilm #biofilms #research #startup

8 years ago, I finished my PhD As I stepped out into the ‘real world’ – I realised despite my (reasonably long by this point) scientific training – I was still missing the most important skill set, how to turn discovery into reality – a skill without which breakthrough languishes at publication 6 years ago, I was determined to rebuild the role of a scientist in society - to not just someone that discovers but also someone that implements that discovery First, I built Spin Up Science to introduce #PhDs and #Postdocs to entrepreneurship and innovation – we’ve now supported 4500 participants across 25 universities 4 years ago, when these academic teams asked for support to launch their companies, we built  Spin Up Ventures - our venture studio – that's now supported just over 200 ventures and directly cofounded 8, of which I’m immensely proud 3 years ago, when our deep science teams kept saying, “general investors are interested, they are waiting for a specialist investor to diligence our science” Johnathan Matlock and I, started Science Angel Syndicate, and united some of the most exceptional and passionate investors in scientific breakthroughs the UK has to offer Today, after we heard “we’re still waiting on a lead science investor” one too many times, we’re excited to announce Empirical Ventures – our first S/EIS fund and new home for all our activities - to lead deep tech investments into the best #deepscience founders at #preseed and #seed across the UK It’s been a long time in the making and we couldn’t have done it without the support of our fantastic team Claudia Fryer, Curran Kalha, Ph.D., Madeleine Nichols, PhD. Our exceptional Venture Partners Alexander Fink and Keith Lipman and all of our LPs in Fund 1. Thank you to all that are aligned with our vision and have supported us along the way. Thanks to the team at British Business Investments and British Business Bank Mark Barry and Luke W. for all the work you put in to helping us through the Regional Angel Fund process. Thanks to SFC Capital Partners Stephen Page, Marguerite Crossfield, Yosra El Hadri Aslah for your guidance and support getting the fund operational. Thanks to Hailey Eustace and Commplicated for supporting with this press release. Thank you to our partners Tom Turner at Abel + Imray and Marla Shapiro at HERMESA. We’ll be supporting capital investment into breakthrough science that links returns and positive impact for the world we live. If you want to know more get in touch or  you can read more here: https://lnkd.in/eiDSpHag #venture #venturecapital #investment #deeptech #deepscience #SEIS #EIS #preseed #seed *CAPITAL AT RISK. FOR PROFESSIONAL INVESTORS ONLY

We’re thrilled to reveal the first 11 companies participating in our Start Accelerator programme! It was a challenge for everyone at Founders at the University of Cambridge to whittle this down to 11 companies but we’re delighted to welcome these dynamic and innovative companies to the fold. Each chosen company includes a founder with a strong connection to the 'University of Cambridge, either as a recent alumni, or a current academic or research student. These teams are taking IP-rich, deep tech ideas, based on years of lab research, and turning them into companies that will help to solve global challenges from climate change to mental health and fixing the food chain. Meet the teams here: https://bit.ly/4cc3ybB 🫧AetoSense - low-cost and high-accuracy indoor air quality monitoring sensors 🦠 BioTryp Therapeutics - dividing bacteria to end overreliance on traditional antibiotics 🧪 BravelyCultured - using proprietary technology to replace petroleum-based products 🧠 Cambridge Vision Technology - early detection of Alzheimer’s 🔋 Molyon - next-generation lithium batteries 💻 Nanomation - building computer vision software for the semiconductor industry 🎈 Orbit - using non-invasive neuro-technology to transform mental health ♻️ Protonera - digesting plastic with sunlight ⚡ VOLTQUANT - fixing the UK electricity grid to enable Net Zero 🩺 William Oak Diagnostics - developing effective testing for micronutrient deficiencies 🧫 xterna - targeting bio-molecule therapy Amongst the teams joining the cohort, there are: - 76% of the cohort hold a PhD - 10 different nationalities including British, American, Dutch, Indian and Lithuanian  - Around one-fifth of the founding teams and over one-third of the CEOs are women Our Start Accelerator companies will receive non-dilutive funding from University of Cambridge and investor partner Parkwalk Advisors, support and mentoring from their own Entrepreneur-in-Residence plus introductions across the Founders network, as well as free office space at ideaSpace and priority access to lab space to conduct their work and research. We’re dedicated to unleashing the innovation that is taking place at Cambridge every day, by giving nascent companies and their founding teams all the tools they need to become successful. With thanks to our sponsors AstraZeneca, KPMG UK, and Hitachi, along with partners Babraham Research Campus and Cambridge Judge Business School. #founders #accelerators #spinouts #innovation

What a night! 💥 The Trinity Bradfield Prize Awards took place last night, you can read all about it in our blog.... Click the link or head up to our bio 👆👆 https://lnkd.in/efHv9cUz #trinitybradfieldprize #cambridge #winners #night #awardsnight Photos: Keith Heppell